Rabeto Tablets 20mg (Rabeprazole Sodium)

Adult dose

Gastric ulcer, duodenal ulcer: Typically administered orally at a dose of 10 mg once daily, with an option to increase to 20 mg once daily based on symptoms. Treatment duration for gastric ulcer is up to 8 weeks, and for duodenal ulcer, up to 6 weeks. Erosive or ulcerative gastroesophageal reflux disease: Administered orally at a dose of either 10 mg or 20 mg once daily for 4-8 weeks. If necessary, an additional course of 10 mg or 20 mg can be administered orally twice daily for 8 weeks (for severe cases).

Child dose

Safety for children has not been established.

This medication should not be administered to patients who have hypersensitivity to certain components or benzimidazole derivatives or have a history of such reactions. Additionally, patients allergic to penicillin-based antibiotics or macrolide antibiotics should refrain from using this medication. In particular, when used for the eradication of Helicobacter pylori, it is essential to verify any allergies to the antibiotics used in combination. This medication is prohibited for use in pregnant or breastfeeding women and should not be used by patients taking certain medications such as atazanavir or rilpivirine. It must be administered cautiously to patients with liver function issues, the elderly, and those with a history of drug allergies, and any adverse reactions should be immediately discussed with healthcare professionals. Various side effects such as skin rashes, itching, blood abnormalities, liver function abnormalities, cardiovascular issues, gastrointestinal disturbances, and neurological symptoms may occur while taking this medication, necessitating regular check-ups and monitoring. It is particularly important to undergo periodic liver function and blood tests, and if abnormal symptoms arise, medication should be promptly discontinued and appropriate measures taken. Long-term use may increase the risk of osteoporosis and fractures, so patients on long-term therapy should pay attention to bone density management. Additionally, as this medication strongly suppresses gastric acid secretion, there may be a slight increase in the risk of gastrointestinal bacterial infections; thus, any abnormal symptoms like diarrhea should be reported to healthcare professionals. Caution should also be taken as drowsiness may occur when driving or operating machinery. There is potential for interactions with other medications; therefore, anyone currently taking other medications should inform their healthcare provider. In particular, caution is needed when used in conjunction with warfarin, methotrexate, antibiotics, and antiviral agents. When taking, the tablets should not be chewed or crushed but swallowed whole, and they should be stored out of the reach of children. During pregnancy or breastfeeding, this medication should not be used, and adjustments in dosing may be necessary for the elderly or patients with impaired liver function if adverse reactions occur. In case of overdose, no specific antidote exists; therefore, treatment and supportive therapy based on symptoms are necessary. Long-term use of this medication may lead to vitamin B12 deficiency, so nutritional status should be checked as needed. Furthermore, symptoms of erythematous lupus may appear after taking this medication, and if such symptoms occur, immediate consultation with healthcare professionals is required.

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. The recommended storage temperature is between 1 to 30 degrees Celsius, maintaining room temperature.

Appearance

Light yellow round enteric-coated tablet

Package unit

Alu Alu - 28 tablets/Alu-Alu[(14 tablets/Alu Alu packaging X 2)]